We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| PPD Inc | NASDAQ:PPD | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 47.28 | 48.00 | 50.00 | 0 | 01:00:00 |
From May 2019 to May 2024
By Jonathan D. Rockoff and Cara Lombardo
Thermo Fisher Scientific Inc. is nearing a deal to buy pharmaceutical-testing company PPD Inc. for more than $15 billion, according to people familiar with the matter, in what would be the latest tie-up among companies that run clinical trials and provide other services for drugmakers.
The companies could finalize a deal as soon as this week, assuming the talks don't fall apart, the people said. PPD has a market value of about $13.6 billion, while Thermo Fisher's is $187 billion.
(More to come)
Write to Jonathan D. Rockoff at Jonathan.Rockoff@wsj.com and Cara Lombardo at cara.lombardo@wsj.com
(END) Dow Jones Newswires
April 14, 2021 16:02 ET (20:02 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year PPD Chart |
1 Month PPD Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
